Surmodics | SRDX - Operating Expenses


Surmodics reported $-245.35M in Operating Expenses for its fiscal quarter ending in September of 2024.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
Align Technology USD 822.85M 11.8M Dec/2025
Anika Therapeutics USD 146.8M 867K Sep/2025
Arrowhead Research USD 223.22M 10.86M Dec/2025
Artivion USD 56.62M 195K Sep/2024
Baxter International USD 3.19B 554.4M Dec/2025
Boston Scientific USD 4.04B 18M Dec/2025
EDAP TMS EUR 18.8M 3.01M Sep/2025
Edwards Lifesciences USD 1.2B 71.3M Dec/2025
Haemonetics USD 134.99M 1.26M Dec/2025
Heron Therapeutics USD 38.47M 4M Sep/2024
J&J USD 18.97B 2.38B Dec/2025
Merit Medical Systems USD 339.74M 1.8M Dec/2025
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Nektar Therapeutics USD 85.09M 109.3M Sep/2025
Option Care Health USD 1.37B 23.44M Dec/2025
Stryker USD 5.2B 505M Dec/2025
Surmodics USD -245.35M 363.49M Sep/2024
Trinity Biotech USD 14.82M 7.81M Sep/2025